OK, we exclude Japan for say the next 12 months and assume if the distributor can't sell much they certainly won't take any more than they can sell, regardless of any contractural arrangements. On the other side of course we have the likes of Taiwan and especially South Korea where IT is already approved. So knock the percentage down to 10%, still gives a rate of 5 million tests a year at the end of this calendar year. 5 million tests would give revenue at the rate of A$100 million a year by end of calendar '08, that's A$25 million a quarter. A massive jump, guess anything is possible but seems very unlikely.
CST Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
